Comparing Treatment With Melatonin to Treatment With Stimulants (Methylphenidate) in Children With Attention Deficit Hyperactivity Disorder and Sleep Difficulties
- Conditions
- Attention Deficit Hyperactivity DisorderSleep Onset Insomnia
- Interventions
- Registration Number
- NCT01393574
- Lead Sponsor
- Assaf-Harofeh Medical Center
- Brief Summary
The study hypothesis is that some children with Attention-Deficit-Hyperactivity-Disorder (ADHD) who also have sleep onset difficulties will improve with Melatonin treatment to an extent similar to that of stimulants treatment.
In order to check this hypothesis children with a new ADHD diagnosis who also have sleep difficulties will be treated with either Melatonin or with stimulants (Methylphenidate) for one month. The main outcome will be improvement of the ADHD symptoms.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 46
- children 6-18 years old with a new ADHD diagnosis who are candidates for treatment with stimulants
- Also they suffer from sleep onset insomnia or difficult awakening
- Drug treatment for ADHD or for sleep problems in the last 6 months
- Any other chronic medical treatment
- Sleep disorder requiring a different treatment
- Asthma in the last 2 years
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Melatonin treatment Melatonin Treatment with Melatonin before sleep for 1 month - 3 mg for body weight \<40kg, 6mg for body weight \>40kg Stimulants treatment Methylphenidate Treatment with Methylphenidate with a formulary and dose as decided by the treating neurologist, for 1 month.
- Primary Outcome Measures
Name Time Method ADHD symptoms improvement a month ADHD symptoms improvement - a clinical judgement based on history from the patient and parents, and from the teacher report
- Secondary Outcome Measures
Name Time Method Sleep difficulties improvement 1 month Sleep difficulties improvement - clinical judgement based on history from the patient and parents and from a sleep diary.
Trial Locations
- Locations (1)
Assaf Haroffeh Medical Center
🇮🇱Zeriffin, Israel